|
original article |
Date |
Title |
Authors All Authors |
1 |
[GO] |
2023―Dec―01 |
COVID-19 Vaccine Practices and Perceptions Among an Academic
Healthcare Community |
Samiksha Prasad, Waseem Wahood, Darisel Ventura Rodriguez, Amanda J. Chase |
2 |
[GO] |
2023―Nov―15 |
Utilization of Telehealth in Kenya During COVID-19 |
Calvin R. Wei, Godwin C. Lang'at |
3 |
[GO] |
2023―Nov―15 |
COVID-19 Pandemic and its Economic Impact on the Global Economy: A Computable General Equilibrium Approach |
Esambe Sone, Jong-Hwan Ko |
4 |
[GO] |
2023―Nov―15 |
Colchicine with Infliximab Compared to Infliximab in Hospitalized Patients with COVID-19 Pneumonia: An Open-label Randomized Trial |
Mahdi Yadollahzadeh, Somayyeh Nasiripour, Najmeh Moradi Shahrbabak, Nader Rezaie, Mohsen Farrokhpour, Mehdi Azimi, et al. (+4) Shirin Izadi, Farhad Zamani, Maryam Farasatinasab, Hootan Diba |
5 |
[GO] |
2023―Nov―15 |
Exploring the Efficacy of Traditional Herbs in Combating COVID-19: A Comprehensive Review |
Anil Sao, Tulsidas Nimbekar, Garla Venkateswarlu, Mohit Mishra, Aditya Kate, Meenakshi Kanwar Chauhan, Chandrashekhar Mahadeo Chakole |
6 |
[GO] |
2023―Nov―15 |
Off-label Use of Medicines in COVID-19: A Lesson For Future |
Aliasghar Hemmati, Hoda Mojiri-Forushani |
7 |
[GO] |
2023―Nov―15 |
Why Poor Countries were the Least Affected by COVID-19? |
Haitham Ahmed Al-Madhagi |
8 |
[GO] |
2023―Nov―15 |
New SARS-CoV-2 Mpro Inhibitor by Ascorbic Acid: Design, Molecular docking, Lipinski’s Rule and ADMET Analysis |
Mohammad Rashid, Md Tanwir Athar, Abdulrahman Salman Alazmi, Deepak Kumar, Raj Kumar, Keun Woo Lee, Aisha Alnami |
9 |
[GO] |
2023―Nov―07 |
Enterococcal Infections: A Comparative Analysis between the Pandemic
and the Pre-pandemic Period |
Neha Sharad, Smriti Srivastava, Vandana V Kiro, Sharin Varma, Sharad Srivastav, Aparna Ningombam, et al. (+2) Rajesh Malhotra, Purva Mathur |
10 |
[GO] |
2023―Nov―06 |
Pandemic Preparedness for COVID-19: Research, Healthcare, and Pharmaceutical Perspectives |
Israel Mani, Manikandan B.N, Amarabalan B, Mohamudha Parveen R, Mohan Pandi |
11 |
[GO] |
2023―Nov―06 |
Polyherbal Syrup for Coronavirus Infection: Formulation and Evaluation |
K. Kranthi Kumar, Sunil Kumar Kadiri, Sampath. A. G |
12 |
[GO] |
2023―Nov―02 |
Biomarkers can Predict COVID-19 Disease |
Utkarsh Sharma, Shikha Sharma |
13 |
[GO] |
2023―Nov―01 |
Traditional Therapies Involving Nutrition for the Management of COVID-19 |
Ramesh M, Arunachalam Muthuraman, Krishnan Anand |
14 |
[GO] |
2023―Nov―01 |
Amidst Cytokine Storm in Metabolic Diseases: Can 2-deoxy-D-glucose (2-
DG) Cure COVID-19? |
Shweta Shrivastava, Ayush Kumar, Manish Kumar Jeengar, Elsy Xavier, Prashant Tiwari |
15 |
[GO] |
2023―Oct―26 |
COVID-19: Different Strains of Corona, Vaccine Efficacy, Treatment, Medical Ethics, and Future Perspectives |
Sonia Singh, Ashima Ahuja, Raghavan Ramankutty, sarada Ramaswamy |
16 |
[GO] |
2023―Oct―25 |
Molecular Docking Analysis of SARS-CoV-2 Inhibitor N3 (6LU7) against
Selected Flavonoids and Vitamins |
Sunil Junapudi, Yasodha Krishna Janapati, Susmitha Uppugalla, Timothy Harris, Muhammad Yaseen, Muhammad Latif |
17 |
[GO] |
2023―Oct―24 |
Phytochemical Profiling of Borassus flabellifer Haustorium and its Potential Role in Combating COVID-19-Associated Encephalopathy: A Computational Perspective |
Noorul Samsoon Maharifa Haja Mohaideen, Hemalatha Srinivasan |
18 |
[GO] |
2023―Oct―17 |
Computational Investigation of Endophytic Fungal (Penicillium citrinum
CGJ-C2) Compound and its In-silico Derivatives on the Inhibition of
RNA-dependent RNA Polymerase of SARS-CoV2 |
Jagadeesha Poyya, Ananda Danagoudar, Chandrasekhar G Joshi, Ajay S Khandagale, Raju N. G |
19 |
[GO] |
2023―Oct―15 |
Efficiency of CAT and L-SIGN as Alternative or Co-receptors for SARS-CoV-2 Spike Protein |
CHAINEE DAS, VENKATA SATISH KUMAR MATTAPARTHI |
20 |
[GO] |
2023―Oct―11 |
Ultrastructural Blood Cell Changes in Patients with COVID-19 |
Yulian Kyyak, Olga Barnett, Olha Labinska, Orysia Kysil, Marta Halkevych |
21 |
[GO] |
2023―Oct―11 |
Mental Health and Stigmatization Linked to the COVID-19 Pandemic |
Sunil Kumar Kadiri, Shakshi Mundhra, Prashant Tiwari |
22 |
[GO] |
2023―Sep―18 |
Barriers and Motivating Factors in Receiving COVID-19 Vaccination among the Healthcare Workers of Tehran Military Hospitals |
Mahmoudreza Hashemi Rafsanjani, Majid Nouri, Ali Omrani Nava, Mohammad Darvishi |
23 |
[GO] |
2023―Sep―14 |
Mechanistic Insights on Viral Factors Involved in Asymptomatic COVID-19 Pathogenesis |
Satinder Kaur, Renu Bala, Prakash Chandra Mishra, Vineeta Singh, Rachna Hora |
24 |
[GO] |
2023―Sep―11 |
A Registry-based Audit of a Current Situation of Clinical Research in COVID-19 Using Artificial Intelligence Techniques: A Systematic Review |
Pugazhenthan Thangaraju, sree sudha ty, Hemasri Velmurugan, Eswaran Thangaraju, Kaumudi Chirumamilla, Tulika Chakrabarti, Prasun Chakrabarti |
25 |
[GO] |
2023―Sep―06 |
Investigation of Reported Anaphylaxis Post COVID-19 Vaccination in Subjects with History of Allergies and Anaphylaxis |
Aditya P. Desai, Aryan P. Desai, Victoria S. Ochs, Prashant V. Desai |
26 |
[GO] |
2023―Aug―25 |
In Silico Study of Alkaloid Compounds with Computational Approach for Selection of Drug Leads for COVID-19 |
Arli Aditya Parikesit, Stephanie Audrey Victoria, Ihsan Tria Pramanda |
27 |
[GO] |
2023―Aug―23 |
Multidrug-resistant Tuberculosis and its Implication with COVID-19 |
Anil Kumar Chhillar, Jasmine Arya, Sweety Dahiya |
28 |
[GO] |
2023―Aug―23 |
Ethical Challenges at the Time of the Covid-19 Pandemic - A Systematic Review |
Pugazhenthan Thangaraju, Hemasri Velmurugan |
29 |
[GO] |
2023―Aug―23 |
Analysis of Research Publication on Logistics at the Time of COVID-19: A Scientometric Study |
Pugazhenthan Thangaraju, Ku Krishna Verma, Hemasri Velmurugan, Himanshu Nirmal Chanu, Tulika Chakrabarti, Prasun Chakrabarti, Sajitha Venkatesan |
30 |
[GO] |
2023―Aug―10 |
My Quarantine Diary: a tool for self-care and learning about COVID-19 |
Alan Maicon de Oliveira, Luana Michelly Aparecida da Costa, Guilherme José Aguilar, Luiz Ricardo Albano dos Santos, Wilbert Dener Lemos Costa, Dantony de Castro Barros Donato, et al. (+2) Felipe Foresto, Valdes Roberto Bollela |
31 |
[GO] |
2023―Aug―04 |
Criticism of the HAS Opinion of July 21st, 2022, on Maintaining of the SARS-Cov-2 Vaccine Mandate for Healthcare Workers |
Jérôme Sainton |
32 |
[GO] |
2023―Aug―01 |
Mucormycosis: A serious catastrophe involving COVID-19 patients |
Neha Dangi, Himanshu Mehendiratta, shikha sharma |
33 |
[GO] |
2023―Jul―27 |
Impact of Prolonged use of COVID-19 Drugs on the Human Neurological System using Insilco Drug-gene Interaction |
Prachi Srivastava, Wayez Naqvi, Prekshi Garg |
34 |
[GO] |
2023―Jul―26 |
Assessment Of Traces Of Sars-Cov-2 Rna In A Laboratory Setting Using In Vitro-Diagnostic Rt-Qpcr |
Arbind Kumar, Sanjay Kumar, Suresh Kumar, Lal Chand Pal, Sahdev Choudhary |
35 |
[GO] |
2023―Jul―10 |
Explaining why Africa had much lower COVID-19 fatalities per million than Europe and North America |
Alberto Boretti |
36 |
[GO] |
2023―Jun―26 |
A Case Report on Covid-19 Causing New Onset of Diabetes Even with No History |
Amit Sharma, Manisha Vohra, Mohammad Amir, Ian Osoro |
37 |
[GO] |
2023―Jun―09 |
A systematic review of covid-19 impact on cardiovascular diseases |
Mohd Zafar Khan, Mohammad Khushtar, Juber Akhtar, Mohammad Irfan Khan, Mohammad Ahmad, Ishana Chand |
38 |
[GO] |
2023―May―09 |
Finding the potential inhibitory activity of Vilanterol Versus Budesonide towards SARS-CoV-2 Mpro: A molecular dynamics simulation approach |
Afzal Hussain, Ashfaq Hussain |
39 |
[GO] |
2023―Apr―18 |
Coronavirus Disease (COVID-19): Features, Diagnosis, Treatments, and Impacts |
Ayush Dogra, Bhawna Goyal |
40 |
[GO] |
2023―Apr―11 |
COVID-19: Mortality rate (in time)
An Analysis of Publicly Available Data from 11 Countries to Calculate the Mortality Rate of COVID-19 |
Rien Bosma |
41 |
[GO] |
2023―Apr―04 |
Herbal Medicines Used for the Management of COVID-19 |
Virender Kumar, Yogesh Kumar, Rajat Huria, Suryadev Kumar, Tarun Kalson, Deepak Jangra, et al. (+2) Davinder Kumar, Bharti Mangla |
42 |
[GO] |
2023―Mar―30 |
Moisturizer and COVID-19: Are We Missing a Trick? |
Srinivasan Tantravahi, Chenna R Galiveti |
43 |
[GO] |
2023―Mar―30 |
Exploring the Possibility of use of SARS-CoV-2 Antiserum as an Alternative for Plasma Therapy |
Basavraj Nagoba, Ajay Gavkare, Abhijit Rayate |
44 |
[GO] |
2023―Mar―30 |
Different Variants of SARS-COV-2: A Comprehensive Review on Mutation Patterns and Pathogenicity |
Mohammad Faheem Khan, Fahmina Rizvi, Mohsin Ali Khan, Waseem Ahmad Ansari, Kajim Ali, Mohd. Aamish Khan |
45 |
[GO] |
2023―Feb―28 |
The Use of Antivirals Against COVID-19 Infection will Reduce the Number of Fatalities in Australia |
Alberto Boretti |
46 |
[GO] |
2023―Jan―03 |
A recent update on SARS-CoV-2 transmission and its variants: Transmission, pathogenic mechanism, and treatment |
Vishal Mishra, Veer Singh, Shreyans K Jain |
47 |
[GO] |
2022―Dec―12 |
Emergence of BA.4/BA.5 Omicron Sub-lineages and Increased SARS-CoV-2 Incidence in Senegal |
Moussa Moise Diagne, Amadou Diallo, Safietou Sankhe, Ndeye Marieme Top, Mouhamed Kane, Maimouna Mbanne, et al. (+6) Martin Faye, Mamadou Aliou Barry, Ndongo Dia, Amadou Alpha Sall, Cheikh Loucoubar, Ousmane Faye |
48 |
[GO] |
2022―Dec―07 |
COVID-19 mortality and the cytokine storm: An added value for APOE genotyping |
Luis Diambra, Reza Rastmanesh |
49 |
[GO] |
2022―Dec―06 |
An In-Silico Multi-Targeted Approach in Search of Potential Drug Candidate(s) Against SARS-CoV-2 Lung Infection |
Joohee Pradhan, Kapish Kapoor, Vishnu Das, Ayushi Bhatnagar, Sunita Panchawat |
50 |
[GO] |
2022―Nov―24 |
Landscape Analysis of Quercetin: A Potential Candidate Against SARS-CoV-2 |
Kamal Niaz, Furqan Shafqat, Shafeeq Ur Rehman, Omazia Nasir, Ayesha Sarwar |
51 |
[GO] |
2022―Aug―30 |
Computational Study Reveals the Inhibitory Effects of Chemical Constituents from Azadirachta Indica (Indian Neem) against Delta and Omicron Variants of SARS-CoV-2 |
Mohammad Faheem Khan, Waseem Ahmad Ansari, Fahmina Rizvi, Mohsin Ali Khan, Zaw Ali Khan |
52 |
[GO] |
2022―Aug―19 |
Examining the Causes of Maternal Mortality in Pregnant Women since the Beginning of the COVID-19 Pandemic in Hamadan Province, Western Iran: A Research Article |
Samereh Ghelichkhani, fariba keramat, Ebrahim Jalili, faezeh moshayedi, Seyedeh Zahra Masoumi, azam midwifery, et al. (+3) mostafa Eghbalian, venus hajialiakbari, fatemeh shahbazi |
53 |
[GO] |
2022―Aug―04 |
The COVID-19 Crisis: Impact on the Education System and How to Change the Way of Learning |
Bentham Science Publisher Bentham Science Publisher |
54 |
[GO] |
2022―Jul―06 |
COVID-19 and Tuberculosis: Two Knives in a Sheath |
Meenakshi Sundaram Kishore Kumar, Attuluri Vamsi Kumar, Thomas Alphonsa, Sangeetha Rajendran, Krishnamurthy Rajamanickam, Alemtoshi A, et al. (+4) Vellingiri Balachandar, Bharali Pranjal, Bupesh Giridharan, Konda Mani Saravanan |
55 |
[GO] |
2022―Jun―24 |
Overview of SARS-CoV-2 and possible targets for the management of COVID-19 infections |
Arunachalam Muthuraman, Muthusamy Ramesh, Aswinprakash Subramanian, Jagadeesh Dhamodharan, Lim Khian Giap |
56 |
[GO] |
2022―Jun―08 |
The COVID-19 Pandemic: To Improve Public Acceptance, Don’t Keep Them in the Dark, Educate Them |
Joseph M. Rosen, Jill R. Sensenig |
57 |
[GO] |
2022―Jun―03 |
In Silico Modeling of COVID-19 Pandemic Course Differentiation Using the FOD Model |
Irena Roterman, Katarzyna Stapor, Piotr Fabian, Leszek Konieczny |
58 |
[GO] |
2022―May―27 |
Engineered Soluble ACE2 Protein and SARS-CoV-2 Variants of Concern (VOCs) |
Wattana Leowattana |
59 |
[GO] |
2022―Apr―11 |
COVID-19 Stress on Mental and Hair Health: A Marker for Diseases in the Post-Pandemic Era? |
Daniela Xavier Accorsi, Ingrid Aparecida Mendes dos Santos, Juliana Xavier Accorsi, Ursulandréa Sanches Abelan, Celso Martin Júnior, Silvia Bohac, et al. (+3) Valéria Bumiller-Bini, Angelica Beate Winter Boldt, Chung Man Chin |
60 |
[GO] |
2022―Mar―29 |
Traditional therapies involving nutrition for the management of COVID-19 |
Ramesh M, Arunachalam Muthuraman, Krishnan Anand |
61 |
[GO] |
2022―Mar―25 |
Functional role of natural antioxidants for controlling oxidative stress associated with SARS-Cov-2 infection |
Subramani Parasuraman, Venkata Kanthi Vaishnavi Vedam, Chakradhara Rao S Uppugunduri |
62 |
[GO] |
2022―Mar―03 |
Recent advances in understanding SARS-CoV-2 infection and updates on potential diagnostic and therapeutics for COVID-19 |
Damini Verma, Amit K. Yadav, Navneet Chaudhary, Maumita Das Mukherjee, Pramod Kumar, Anil Kumar, Pratima R Solanki |
63 |
[GO] |
2022―Feb―06 |
The Concept Of Repurposing In Covid-19 Infection |
Lata Potey, Anshu Chaudhary Dudhe, Dhanashri Tumme, Rupesh Dudhea, Prafulla Sable |
64 |
[GO] |
2022―Jan―24 |
Green tea catechins against COVID-19? Lower COVID-19 morbidity and mortality in countries with higher per capita green tea consumption. |
Maksim Storozhuk |
65 |
[GO] |
2022―Jan―19 |
Assessment of Stress, Anxiety and Depression Level Among COVID-19 Positive Patients Admitted in Rural Tertiary Care Hospital |
Ramakant Yadav, Neha Dubey, Shweta Jain, Ankur Vaidya, Raj Kumar |
66 |
[GO] |
2022―Jan―18 |
Onco-immunological Aspect of COVID-19: Current Progress and Perceptions |
Suman Kumar Ray, Sukhes Mukherjee |
67 |
[GO] |
2022―Jan―18 |
LONG TERM NEUROLOGICAL EFFECTS AFTER ACUTE SARS-CoV-2 INFECTION |
Mohammad Asif |
68 |
[GO] |
2022―Jan―07 |
Is there a rendezvous for SARS-CoV-2 and Agmatine? |
Nandkishor Kotagale, Brijesh Taksande, Nazma Inamdar |
69 |
[GO] |
2021―Nov―23 |
Impact on Pharmaceutical Industry due to Sudden Pandemic Attack (COVID-19) |
Sudhanshu Mishra, Disha Sharma, Shobhit Prakash Srivastava, Swati Verma, Rishabha Malviya |
70 |
[GO] |
2021―Oct―23 |
Liver and Covid-19 - a review and clinical approach |
David L Fisher, Stephen Malnick |
71 |
[GO] |
2021―Sep―16 |
Alternative Management Of Cushing's Syndrome During Covid-19 Pandemic |
Serghei Covantev, Stanislav I. Volkov, Kristina I. Samsonova |
72 |
[GO] |
2021―Sep―16 |
Cytokine Storm and Immunomodulation in COVID-19: a Review |
Amir Mohammad Arsh, Suhana Mishra, Vishwas Tripathi, Amaresh Mishra |
73 |
[GO] |
2021―Sep―13 |
Cordycepin and its nucleoside analogs for the treatment of systemic COVID-19 infection |
|
74 |
[GO] |
2021―Sep―09 |
Total Stromal Fraction (TSF) - Fortified Adipose tissue-derived Stem Cells Source: An Emerging Regenerative Realm Against COVID-19 Induced Pulmonary Compromise |
Madhan Jeyaraman, Sathish Muthu, Rashmi Jain, Ajay SS, Neha Garg, Prabhu Mishra, et al. (+10) Kumari Swati, Anand Parkash, Niraj Kumar Jha, Shreesh Ojha, Shubhadeep Roychoudhury, Dhruv Kumar, Janne Ruokolainen, Mohammad Amjad Kamal, Kavindra Kumar Kesari, Saurabh Kumar Jha |
75 |
[GO] |
2021―Aug―23 |
Withdrawal Notice: Therapeutically Important Natural Products and their Derivatives as a Target for Treatment of COVID-19 (SARSCoV2) |
Ashu Chaudhary |
76 |
[GO] |
2021―Aug―06 |
History, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19) |
Amaresh Mishra, Nisha Nair, Vishwas Tripathi, Yamini Pathak, Jaseela Majeed |
77 |
[GO] |
2021―Jul―29 |
COVID-19 Vaccines: Fabrication Techniques and Current Status |
Ayushi Mahajan, Lakhvir Kaur, Gurjeet Singh, RK Dhawan, Lovepreet Singh, Anureet Kaur |
78 |
[GO] |
2021―Jul―12 |
Identification of flavonoids as potent inhibitors against MERS-CoV 3C-like protease |
Fatemeh Abdi, Shahrzad Javanshir |
79 |
[GO] |
2021―Jul―12 |
SARS-CoV-2: Evaluation and Evolution |
Loay Bedda, Fayrouz Mahmoud, Radwa Elkhateib, Alyaa Dawoud, Hassan Gamal, Abdallah S. Abdelsattar, Ayman El-Shibiny |
80 |
[GO] |
2021―Jun―02 |
Immunosuppressant Drugs And Covid-19: Associated Risks, Drug-Drug Interactions & Contraindications |
Debjyoti Talukdar, Diane Ignacio, Madan Mohan Gupta |
81 |
[GO] |
2021―Mar―30 |
Lipid lowering natural products targeting hPCSK9 may prevent the severity of COVID-19 infection |
Ajoy Basak, Jaishree Vaijanathappa, Sarmistha Basak |
82 |
[GO] |
2021―Mar―30 |
Graphene versus coronavirus: A study of the graphene properties that can help to combat coronavirus |
T. Guerra, I. O. Assis, A. B. Guerra |
83 |
[GO] |
2021―Mar―16 |
Administration of exogenous surfactant and cytosolic phospholipase A2α inhibitors may help COVID-19 infected patients with chronic disease |
Mohammed Abdalla Hussein |
84 |
[GO] |
2021―Mar―10 |
Transmission, Prevention and Therapeutic Strategies for COVID-19: Updates and Challenges |
Habibur Rahman |
85 |
[GO] |
2021―Mar―10 |
New Perspectives for SARS-CoV-2 Rapid Detection |
Latifa Khattabi, Mustapha Mounir Bouhenna, Feriel Sellam |
86 |
[GO] |
2021―Mar―03 |
Effect of miRNAs, proinflammatory cytokines and ACE2 in COVID-19 pathophysiology |
Hari Om Singh, Kamini Jakhar, Vijay Nema, Asha Krishnaraj, Ranjana Choudhari |
87 |
[GO] |
2021―Mar―01 |
Therapeutically Important Natural Products and their Derivatives as a Target for Treatment of COVID-19 (SARSCoV2) |
Ashu Chaudhary |
88 |
[GO] |
2021―Mar―01 |
Economic Fluctuations- the Aftermath of COVID 19 Pandemic |
Saishiv Adithya, Koyeli Girigoswami |
89 |
[GO] |
2021―Feb―26 |
SARS-CoV-2: Molecular biology and therapeutic target. |
Vivek Pandey, Ankita Pathak, Mohammad Shahar Yar, Yuba Raj Pokharel |
90 |
[GO] |
2021―Feb―25 |
Antimicrobial Resistance: The Potent Enemy Lurking Behind COVID-19 |
Rohini Kanwar, Amit Kumar, Jyoti Rathee, Surinder K. Mehta |
91 |
[GO] |
2021―Feb―24 |
World’s proposed safeguard against COVID-19 - A brief review |
Sumanta Dey, Anindita Dey, Shreyans Chatterjee, Papiya Nandy, Ashesh Nandy |
92 |
[GO] |
2021―Feb―24 |
Controlling Coronavirus Infection: ‘Plan B’ based on non-vaccine/drug interventions |
Ram Kumar Dhaked |
93 |
[GO] |
2021―Feb―24 |
Clinical evidence and therapeutic treatments at the time of the coronaviruses responsible for SARS: a perspective and points of view with a focus on vascular endothelium. |
Gerardo Tricarico, Barbara Zavan, Valter Travagli |
94 |
[GO] |
2021―Feb―24 |
Current Trends and Future Strategies for the Global Impact of COVID-19 Pandemic |
Ashutosh Chauhan, Ankit Kumar, Sandeep Goyal, Sunil Kumar Joshi, Deepak Kumar Semwal |
95 |
[GO] |
2021―Feb―23 |
Virtual Screening of the Flavonoids Compounds with the SARS-CoV-2 3C-like Protease as the Lead Compounds for the COVID-19 |
Gabriella Patricia Adisurja, Arli Aditya Parkesit |
96 |
[GO] |
2021―Feb―23 |
Functionalized photocatalytic nanocoatings for inactivating COVID-19 virus residing on surfaces of public and healthcare facilities |
Manjunatha Channegowda |
97 |
[GO] |
2021―Feb―23 |
Angiotensin Converting Enzyme-2: A Doorway for SARS-CoV-2 |
Vikas Pandey, Indu Lata Kanwar, Tanweer Haider, Vishal Gour, Monika Vishwakarma, Avijit Kumar Bakshi, et al. (+2) Ravishankar Yadav, Vandana Soni |
98 |
[GO] |
2021―Feb―17 |
The synergic role of environmental contaminants on the immunological effects of viral diseases, such as COVID-19 |
Winfred Espejo, José E Celis, Paulina Bahamode |
99 |
[GO] |
2021―Feb―17 |
Screening for Potential Traditional Herbal Inhibitors Against 3-Chymotrypsin-Like Main Protease (3CLpro) from Four Different Coronaviruses-: An in-silico Approach |
Prachi Singh, Mohamed Rafiq, Raghavendra Pralhada Rao |
100 |
[GO] |
2021―Feb―17 |
Immunological response of the respiratory tract in the SARS-CoV-2 infection |
Sanjiv Singh, Punita Aggarwal, Velayutham Ravichandiran |
101 |
[GO] |
2021―Feb―17 |
Prevention and management of SARS-CoV-2 infection among the health care workers |
Juhi Sharma, Divakar Sharma |
102 |
[GO] |
2021―Feb―12 |
Mesenchymal stem cells: A potent cell source for COVID-19 |
Mohammad Ramazii, Delnia Ebadi, Maryam Farzaneh, Farhoodeh Ghaedrahmati, Seyed Esmaeil Khoshnam |
103 |
[GO] |
2021―Feb―12 |
High Mutation Rate Leads to Fitness Loss for Coronavirus Quasispecies |
Khalid P, Arun A. Bhagwath, Rekha P.D, Sharif Hamed R. Almutiri, Ziyad Abdullah Al Zeyadi, Suman V. Budihal |
104 |
[GO] |
2021―Feb―11 |
An epidemiology, evolution, transmission, and therapeutics of COVID-19 Outbreak: an update on the status |
Karan Singh, Amit Kumar Mittal, Akash Gujral |
105 |
[GO] |
2021―Feb―09 |
An Integrated In-Silico Approach to Develop Epitope-Based Peptide Vaccine against SARS-CoV-2 |
Prekshi Garg, Neha Srivastava, Prachi Srivastava |
106 |
[GO] |
2021―Feb―09 |
COVID19 pandemic: An overview of its origin, current status and ongoing clinical trials |
Kartik Majila, Seema Lal, Mohammad Faiz Ahmad |
107 |
[GO] |
2021―Feb―04 |
Pathogenesis and immune status in COVID-19 pneumonia - A minireview |
George Laylson da Silva Oliveira, Nidia Aparecida Martines, Joelma da Costa Barbosa Oliveira |
108 |
[GO] |
2021―Feb―03 |
COVID-19 invades several important organs other than lungs: Organs crosstalk |
Manal A. Hamed |
109 |
[GO] |
2021―Feb―03 |
Promiscuous Biological Features of Newly Emerged SARS-CoV-2 Facilitate its Unrestrained Outbreak: An Update |
Asim Azhar, Khaled Al-hosaini, Parvez Anwar Khan, Abdul M Oanz, Qamar Zia, Saeed Banawas, et al. (+3) Jae-Jung Dong, Mohammad Amjad Kamal, Mohammad Owais |
110 |
[GO] |
2021―Jan―31 |
Adjuvant Therapies of COVID-19 - A Literature Review |
Naina Mohamed Pakkir Maideen |
111 |
[GO] |
2021―Jan―28 |
Diagnosis and possible use of Traditional Medicinal Plant to combat COVID-19 |
M. Beyau Konyak, Richa Naredi, Ekta Rana, Ramendra Pati Pandey |
112 |
[GO] |
2021―Jan―28 |
Antiviral Effects of Asian Natural Products Targeting SARS, MERS, and COVID-19. |
Jafrin Jobayer Sonju, Md Rafi Anwar, Md. Abul Kalam Azad, Umme Habiba Sultana, Kumar Kulldeep Niloy, Sajan Das |
113 |
[GO] |
2021―Jan―19 |
History and global status of the new coronavirus covid-2019 and aspects of previous infections of sars-cov and mers-cov: A systematic review |
Amanda Pinato Alves da Costa, Vinicius Lisboa da Rocha, Rogério Rodrigo Ramos, José Martins Pinto Neto, Wagner Rafael da Silva, Luis Lenin Vicente Pereira, et al. (+4) Kelys Ramos, Tais Cristina Nascimento Marques, Idiberto José Zotarelli Filho, André Wilian Lozano |
114 |
[GO] |
2021―Jan―19 |
In silico insight into the inhibitory effects of active antidiabetic compounds from medicinal plants against SARS-CoV-2 replication and posttranslational modification |
Habibu Tijjani, Adamu Idris Matinja, Ahmed Olatunde, Maryam Haladu Zangoma, Abubakar Mohammed, Muhammad Akram, et al. (+2) Akinwunmi Oluwaseun Adeoye, Hamza Lawal |
115 |
[GO] |
2021―Jan―18 |
A coadunation of biological and mathematical perspectives on the pandemic COVID-19: A Review |
Sahar Qazi, Kayenat Sheikh, Mo Faheem, Arshad Khan, Khalid Raza |
116 |
[GO] |
2021―Jan―13 |
COVID-19 and the challenges of chemotherapy: The failure case of hydroxychloroquine in the clinical treatment of SARS-CoV-2 infection |
Pollyanna Stephanie Gomes, Patrícia A. Machado, Andre M. O. Gomes, Andrea C. Oliveira, Jerson L. Silva, Herbert Leonel de Matos Guedes |
117 |
[GO] |
2021―Jan―13 |
COVID-19 (SARS-CoV2): Consequences, Possible Therapeutics and Future Directions for Prevention & Treatment |
Ashu Chaudhary |
118 |
[GO] |
2021―Jan―13 |
Immunity modulators, Repurposed drugs and Candidate Vaccines for COVID-19: A Review |
Rashmy Nair, Ravindra Singh Rao, Placheril Joseph John, Poonam Khandelwal |
119 |
[GO] |
2021―Jan―12 |
A Mini Review on COVID-19 Therapeutics: Current Status and Future Directions |
Niranjan Kaushik, Vikram Sharma, Vikas Sharma |
120 |
[GO] |
2021―Jan―11 |
Cellular senescence and COVID-19 |
Farhan Rahman Chowdhury, Tofazzal Islam |
121 |
[GO] |
2021―Jan―11 |
Hydroxychloroquine Sulfate (Plaquenil): A possible candidate for Pandemic SARS-CoV-2 or (COVID-19) ? |
Subhash Chandra, Sarla Saklani, Hassan Y. Aboul-Enein |
122 |
[GO] |
2021―Jan―08 |
Stroke and COVID-19 pandemic: the dilemma |
Sherif Mohamed, Seham Abd El-Mohsen, Osama Abo El-Hassan, Azza AbdelHaffez, Nashwa Abd El-Aziz |
123 |
[GO] |
2021―Jan―06 |
Safe Use of Sodium Dodecyl Sulfate (SDS) to Deactivate SARS-CoV-2: An Evidence-Based Systematic Review |
Ashok Kumar, Waseem Ahmad Ansari, Tanveer Ahamad, Mohammad Saquib, Mohammad Faheem Khan |
124 |
[GO] |
2021―Jan―04 |
Is COVID-19 a systemic disease? |
Sherif Mohamed, Khaled Saad, Ghada Elgohary, Azza AbdElHaffez, Nashwa Abd El-Aziz |
125 |
[GO] |
2021―Jan―04 |
Remdesivir (GS-5734) for COVID-19 Treatment: Past and Recent Updates |
Santhosh Arul, Haripriya Dayalan |
126 |
[GO] |
2021―Jan―03 |
Psychological Impact of Coronavirus (COVID-19) Disease on Cancer Patients |
Gaurav Dhiman |
127 |
[GO] |
2020―Dec―31 |
Repositioning of Drugs as a promising strategy to fight COVID-19 |
Vivek Yadav, Jurnal Reang, Vinita Sharma, Jaseela Majeed, Swaminathan Jambulingam, Ramesh Goyal, Rajiv Kumar Tonk |
128 |
[GO] |
2020―Dec―31 |
A critical appraisal of the risk of bias in systematic reviews and metaanalyses pertaining to COVID-19 |
Amit Dang, Sheshank Madiraju, Jagan Mohan Venkateswara Rao P, Navya Sri Gurram, Sandeep Digijarala, Sumit Dang, Vallish BN |
129 |
[GO] |
2020―Dec―31 |
2019 Novel Coronavirus: A review on Epidemiology, Pathophysiology, Diagnosis and Current Clinical Trials in Vaccine Development |
Megala Jayaraman, Sabari Krishna B. B., Parijat Dutta, Jayesh Telang, Sreshta Adhikari, Arpan Neeraj Pardeshi |
130 |
[GO] |
2020―Dec―31 |
Pleiotropic effects of Nitric Oxide on SARS-CoV-2 Infections |
Barbara Terroni, Juliana Romano Lopes, Chung Man Chin, Jean Leandro Dos Santos |
131 |
[GO] |
2020―Dec―29 |
Management of COVID-19 very elderly patients in Nursing Homes and Long-Term Care Facilities: Description of a new model and experience in a medicalized Nursing Home |
Ignacio Novo-Veleiro, Martín Vidal-Vazquez, Néstor Vázquez-Agra, Eduardo-David Otero Rodríguez, Paula Andújar-Plata, Belen Calvo-Martínez, et al. (+5) Irene Espasandín-Duarte, Francisco Javier Martínez-Bahamonde, Beatriz Pais-Iglesias, Eloína Núñez-Masid, Antonio Pose-Reino |
132 |
[GO] |
2020―Dec―24 |
A Perspective On The Impact of COVID-19 Pandemic in Basic Science Research and its Future implications |
Yam Nath Paudel, Efthalia Angelopoulou, Bhupendra Raj Giri, Christina Piperi, Iekhsan Othman, Mohd. Farooq Shaikh |
133 |
[GO] |
2020―Dec―24 |
In-silico Discovery of Fungal Metabolites Bergenin, Quercitrin and Dihydroartemisinin as Potential Inhibitors against Main Protease of SARS-CoV-2 |
Ravi S Patel, Akash G Vanzara, Nimisha R Patel, Ajit M Vasava, Sachin M Patil, Kishore S Rajput |
134 |
[GO] |
2020―Dec―23 |
Current Drug Trends for the Treatment of SARS-CoV-2 |
Márcio Robert Mattos da Silva, Melanie Tavares, Ralph Santos-Oliveira, Eduardo RicciJúnior |
135 |
[GO] |
2020―Dec―23 |
Boosting innate immunity during SARS-CoV-2 clearance |
Abhishesh Kumar Mehata, Deepa Dehari, Anuj Kumar Mehta, Alim Miya |
136 |
[GO] |
2020―Dec―21 |
Impact of Metaheuristic Techniques in Pandemic of COVID-19 |
Vijay Kumar, Dilbag Singh, Manjit Kaur |
137 |
[GO] |
2020―Dec―21 |
The Significance of Angiotensin-Converting Enzyme-2 (ACE2) in SARSCov-2 Infection and COVID-19 |
Carolina Restini, Trevor Belavek, Rafael Bernal, Vanessa Ibrahim, Kelly Irwin, Minjung Kim, Courtney Merlo |
138 |
[GO] |
2020―Dec―21 |
Molecular insights into Resveratrol and its analogs as SARS-CoV-2 (COVID-19) protease inhibitors |
Vaishali M. Patil, Rohan R. Narkhede, Neeraj Masand, Rameshwar S. Cheke, Krishnan Balasubramanian |
139 |
[GO] |
2020―Dec―21 |
Remdesivir, A Potential Drug for COVID-19 Treatment: A New Hope |
Kuldeep Singh, Dilpreet Singh, Karan Razdan |
140 |
[GO] |
2020―Dec―15 |
Coronavirus Pandemic: Role of Bats And Zoonotic Transmission in Humans |
Baljinder Singh, Jasleen Kaur, Sumeet Gupta |
141 |
[GO] |
2020―Dec―15 |
Review on Diagnostic Methods for SARS-CoV-2 |
Chandrashekhar Chauriya, Mahesh Sahu, Anuj Kumar Singh, Amita Verma |
142 |
[GO] |
2020―Dec―10 |
COVID-19: how nuclear medicine can provide a differential diagnosis in very dubious case |
Maria Silvia De Feo, Viviana Frantellizzi, Giuseppe De Vincentis |
143 |
[GO] |
2020―Dec―10 |
The Genomes of SARS-CoV-2 and Related Coronaviruses: Are Accessory Proteins Key for Pathogenesis? |
Saikat Samanta, Rudra Prasad Saha |
144 |
[GO] |
2020―Dec―10 |
Nigella Sativa: An immunity booster as pandemic treatment solution against SARS-CoV-2 |
Afzal Hussain, Ashfaq Hussain, Chandan Kumar Verma |
145 |
[GO] |
2020―Dec―10 |
The role of nanoparticles as nanocarriers for the controlled release of some potential existing antiviral drugs for SARS-CoV-2 management: A Review |
Onome Ejeromedoghene, Joshua I. Orege, Justina U. Onwuka, Philip A. Adebule, Teddy Ehianeta, Bright O. Okonkwo, Richard O. Akinyeye |
146 |
[GO] |
2020―Dec―10 |
SARS-CoV-2: Origin, pathogenesis and Therapeutic Interventions |
Ipsita G Kundu, NNV Radharani, Amit S Yadav, Srinivas Patnaik, Gopal C Kundu |
147 |
[GO] |
2020―Dec―05 |
Recent developments and opportunities in fighting COVID-19 |
Vikram Rao, Subrat Kumar Bhattamisra |
148 |
[GO] |
2020―Dec―05 |
Outbreak of coronavirus disease 2019 (COVID-19) and its manifestation |
Bikash Debnath, Waikhom Somraj Singh, Kuntal Manna |
149 |
[GO] |
2020―Dec―05 |
Major drugs used in COVID-19 treatment: molecular mechanisms, validation and current progress in trials |
Md. Asaduzzaman Khan, Shad Bin Islam, Mejbah Uddin Rakib, Didarul Alam, Md. Munnaf Hossen, Mousumi Tania, Asaduzzaman Asad |
150 |
[GO] |
2020―Dec―05 |
Safety and Efficacy of Convalescent Plasma Therapy for the Management of COVID-19: A Systematic Review |
Sitaram Khadka, Muhammad Saleem, Dhan Bahadur Shrestha, Pravash Budhathoki |
151 |
[GO] |
2020―Dec―05 |
Covid-19: An update on the clinical features, diagnosis, and treatment strategies. |
Manan Abdulrahman Alhkbany |
152 |
[GO] |
2020―Dec―05 |
Therapeutic options for the treatment of 2019-novel coronavirus in India: A systematic review |
Pratyay Kumar Pahari, Sonal Vyas, Shahbaz Aman, Uday Singh, Kusheswar Prasad Singh, Rohit Tiwari, Meenakshi Dhanawat |
153 |
[GO] |
2020―Dec―04 |
Chemi-Informatic approach to investigate putative pharmacoactive agents of plant origin to eradicate COVID-19 |
Amit Joshi, Vandna Sharma, Joginder Singh, Vikas Kaushik |
154 |
[GO] |
2020―Dec―04 |
In silico identification of potential inhibitors of SARS-CoV-2 papain-like protease from natural sources: A natural weapon to fight COVID-19 |
Bimal Debnath, Pradip Debnath, Rajat Ghosh, Sudhan Debnath |
155 |
[GO] |
2020―Dec―04 |
Coronavirus (Covid-19) and employee health |
Ali Mehrabi Tavana, Mohamadkarim Bahadori |
156 |
[GO] |
2020―Nov―24 |
COVID-19: A daily dose of yoga to cope with anxiety |
Surabhi Gautam, Rima Dada |
157 |
[GO] |
2020―Nov―24 |
Is there any role for IL-6 inhibition in COVID-19? |
Rebecca Cannon, Satyajit Das |
158 |
[GO] |
2020―Nov―24 |
The emergence of novel coronavirus disease, global treatment update and its containment strategies in overpopulated countries: A Review |
Fazli Azim, Md Shahidul Islam, Hedaeytullah Saju, Kaniz Fatema, Aneela Hayat, Mostofa Kamal, et al. (+3) MD Sarfraz, Nawshad Muhammad, Syed A. A. Rizvi |
159 |
[GO] |
2020―Nov―20 |
COVID-19 Effect: Time to Change the Way of Research |
Vikas Sharma |
160 |
[GO] |
2020―Nov―20 |
Structure, transmission, diagnostic symptoms, host and entry mechanism of covid-19: A review |
Prashant Swapnil, Mukesh Meena, Tansukh Barupal, Yashwant Sompura, Deepa Hada |
161 |
[GO] |
2020―Nov―20 |
A Journey of Coronaviruses from Sporadic Outbreaks to COVID -19 Pandemic |
Suresh Kumar, Perumal Nagarajan |
162 |
[GO] |
2020―Nov―19 |
Clinical spectrum, geographical variability of COVID-19 and its implications |
Md. Hasanul Banna Siam, Abdullah Al Mosabbir, Nahida Hannan Nishat, Ahsan Ahmed, Mohammad Sorowar Hossain |
163 |
[GO] |
2020―Nov―19 |
Psychological and Mental Health Issues During SARS-CoV-2 Global Pandemic: A Critical Analysis |
Tahmeena Khan, Iqbal Azad, Alfred J. Lawrence |
164 |
[GO] |
2020―Nov―17 |
Impact of Novel Coronavirus (COVID-19) on Pregnant Women: A Review |
Saima Habeeb, Manju Chugani |
165 |
[GO] |
2020―Nov―17 |
Current advances in novel SARS-CoV-2 disease (COVID-19) treatment and intervention strategies |
Mohammad Khalid Parvez, Kartika Padhan |
166 |
[GO] |
2020―Nov―17 |
Anticipating on a post covid-19 world and the pivotal role of science and technology |
Saeed Khan, Tusha Sharma, Basu Dev Banerjee, Scotty Branch, Shea Harrelson |
167 |
[GO] |
2020―Nov―13 |
COVID-19 Pandemic: Current Scenario, Challenges and Future Perspectives |
Ovais Ahmad Zargar, Rabia Hamid, Rohina Bashir, Mohammad Afzal Zargar |
168 |
[GO] |
2020―Nov―13 |
Structure based drug design approach to identify potential SARS-CoV-2 polymerase inhibitors. |
Preeya Negi, Surya Prakash, Vaishali M. Patil |
169 |
[GO] |
2020―Nov―11 |
Novel Coronavirus Disease 2019 (COVID-19) Current Update; Perspective on Epidemiology, Diagnosis, Drug Targets and Vaccines |
Sunil L. Harer, Priyanka A. Sonar |
170 |
[GO] |
2020―Nov―05 |
Antiviral potential of coconut (Cocos nucifera L.) oil and COVID-19 |
Ramesh S.V., Pandiselvam R, Hebbar K. B., Manikantan M.R., Shameena Beegum P.P., Shelly Praveen, Sruthi N. U |
171 |
[GO] |
2020―Oct―27 |
A Mini-review on Cardiovascular and Hematological Complications of COVID-19 |
Moein Masjedi, Pegah Jafari |
172 |
[GO] |
2020―Oct―27 |
The Current Outbreak of COVID-19 with reference to India |
Harshita Gupta |
173 |
[GO] |
2020―Oct―27 |
Review of the Times When One-Third of the Mankind is Under Lockdown due to Coronavirus |
Pramod Gware, Deepanshu Gulati |
174 |
[GO] |
2020―Oct―27 |
Vaccine development against SARS-CoV-2: from virology to vaccine clinical trials |
Kimia Kardani, Azam Bolhassani |
175 |
[GO] |
2020―Oct―27 |
Manuscript title: “COVID-19 pandemic: care for Indian cancer patients” |
Sandeep Kumar |
176 |
[GO] |
2020―Oct―23 |
Nanomaterial: A Sustainable Way to Fight against COVID-19 |
Atish K. Maldhure |
177 |
[GO] |
2020―Oct―18 |
Combination of Hydroxychloroquine, Melatonin and Mercaptopurine as possible intervention for prophylaxis and treatment of Novel COVID-19 infection |
Gyan Vardhan, Vikas Kumar, Megha Agrawal, Puneet Dhamija |
178 |
[GO] |
2020―Oct―15 |
A Study about the impact of weather, life expectancy and tourism on the transmission of COVID-19 |
Pardeep Bishnoi, Prabhat Kumar, Abhijeet Singh, Mukesh Sahu, Vikrant Bansal |
179 |
[GO] |
2020―Oct―15 |
Synthetic Lung Surfactant Treatment for Covid-19 Pneumonia |
Frans J. Walther, Alan J. Waring |
180 |
[GO] |
2020―Oct―15 |
Emergence of a new zoonotic covid-19 that creates a pandemic: Update on current pharmacotherapeutics and future prospective of plasma therapy |
Farazul Hoda, Rishabh Verma, Saurabh Rastogi, Asif Iqubal, Syed Ehtaishamul Haque, Mohd. Akhtar, Abul Kalam Najmi |
181 |
[GO] |
2020―Oct―15 |
Possible benefits of reformulating antiviral drugs with nanoemulsion system in the treatment of novel coronavirus infection |
Manish Kumar, Chandra Prakash Jain |
182 |
[GO] |
2020―Oct―15 |
In-silico Structure-Based Drug Discovery of Candidate Drugs against Novel Protein Receptor Complex Nsp10-Nsp16 of SARS-CoV-2 using Drug Repurposing Approach |
Abhishek Sengupta, Pooja Vijayaraghavan, Priyansh Srivastava, Lovely Gupta, Chaitanya Chandwani, Priyanka Narad |
183 |
[GO] |
2020―Oct―07 |
Impact of Online Teaching on Students’ Education and Health in India during Pandemic of COVID-19 |
Avadhesh Kumar Yadav |
184 |
[GO] |
2020―Oct―07 |
Impact of BCG Vaccine to Fight Against the Pandemic of Corona (COVID-19): A Review |
Rana Mazumder, Subhabrota Majumdar |
185 |
[GO] |
2020―Oct―07 |
Coronavirus disease 2019 (COVID-19): Current situation and therapeutic options |
Veer Singh, Vishal Mishra |
186 |
[GO] |
2020―Oct―07 |
COVID-19 Epigenetics and Implications for Public Health |
Verda Tunalıgil, Gülsen Meral, Ahmet Katı, Dhrubajyoti Chattopadhyay, Amit Kumar Mandal |
187 |
[GO] |
2020―Oct―07 |
Nutritional intervention for the treatment and prevention against novel coronavirus-19 |
Abdul Wahab, Fahad Hassan Shah |
188 |
[GO] |
2020―Sep―29 |
Dual modulators of selected plant secondary metabolites targeting COVID-19 Main protease and Interleukin-2: An in-silico approach based novel hypothesis |
Thangavelu Prabha, Vijay K. Kapoor, Palanisamy Selvamani, Subbiah Latha, Thangavel Sivakumar, Selvaraj Jubie |
189 |
[GO] |
2020―Sep―29 |
Hydroxychloroquine Induced DRESS (Drug Rash with Eosinophilia and Systemic Symptoms Syndrome) Mimicking SARS-COV-2 Illness: A Case Report with Review |
Maitri M. Patel, Dhruvkumar M. Patel, Mukundkumar V. Patel, Jayanti K. Gurumukhani, Suyog Y. Patel, Harsh D. Patel |
190 |
[GO] |
2020―Sep―26 |
COVID-19 infection: A review of summarized Clinical trials study for the treatment |
Afzal Hussain, Ashfaq Hussain, Chandan Kumar Verma |
191 |
[GO] |
2020―Sep―22 |
Novel Corona-Virus Disease 2019 (COVID-19): A Perilous LifeThreatening Epidemic |
Surya Goel, Ram Dayal |
192 |
[GO] |
2020―Sep―22 |
Discovery of Potential Inhibitors of SARS-CoV-2 (COVID-19) Main Protease (Mpro) from Nigella Sativa (Black Seed) by Molecular Docking Study |
S. L. Khan, F. A. Siddiqui, S. P. Jain, G. M. Sonwane |
193 |
[GO] |
2020―Sep―22 |
COVID-19: Mitigation is good! Prophylactics are better! Treatment is the best! |
Prabagaran Narayanasamy |
194 |
[GO] |
2020―Sep―21 |
Understanding the role of HDL during COVID-19 infection |
Iti Garg, Swati Srivastava, Bhuvnesh Kumar |
195 |
[GO] |
2020―Sep―21 |
COVID-19: Insights into Structure-Function Relationship, Drug Targets and Drug Design Strategies for novel-Coronavirus 2019 |
Snigdha Bhardwaj, Shaminder Singh, Sonam Bhatia |
196 |
[GO] |
2020―Sep―18 |
Coronavirus: history, genome structure and pathogenesis |
Poonam B, Prabhjot Kaur Gill |
197 |
[GO] |
2020―Sep―18 |
A Review on Catastrophic Evolution of SARS-CoV to SARS-CoV2-A Global Pandemic |
Sushmita Krishnan, Darshini Subramanian, Sri Sakthi Priyadarshini Rajamani |
198 |
[GO] |
2020―Sep―16 |
Insights into the Positive Role of a Higher Education Institution in the Prevention of Misinformation During Pandemics: The Health Committee Model During COVID-19 |
Dalal Hammoudi Halat, Marwan Akel, Fatima Hajj, Hassan HajjHussein, Rawad Kansoun, Ehsan Sharif-Askari, et al. (+2) Lama Siblani, Ahmad Faraj |
199 |
[GO] |
2020―Sep―16 |
Yoga may prevent cytokine storm in COVID-19 |
Surabhi Gautam, Rima Dada |
200 |
[GO] |
2020―Sep―16 |
Utilizing Zebra fish animal model as a helping hand for COVID-19 infection |
Yashbir Singh, Heenaben Patel, Amit Chaudhary, Deepa S |
201 |
[GO] |
2020―Sep―16 |
Dental care during the COVID-19 pandemic. |
Caio Vinicius G. Roman-Torres, Marcelo de Melo Quintela |
202 |
[GO] |
2020―Sep―16 |
Prediction of infection and death ratio of CoVID-19 virus in Turkey by using artificial neural network (ANN) |
Andaç Batur Çolak |
203 |
[GO] |
2020―Sep―16 |
Covid-19: An Insight over the Third Respiratory Global Emergency of the Century |
Sonali Batra, Sumit Sharma, Payal Verma, Nikhil Arora |
204 |
[GO] |
2020―Sep―16 |
Can Cannabinoids Suppress the Cytokines Cascade in Patients with Coronavirus Disease COVID-19? A mini-review |
Hanane Zaki, Mohammed Bouachrine |
205 |
[GO] |
2020―Sep―15 |
Vitamin D3 Deficiency and COVID-19. |
Olen R. Brown, Martin R. Hullender |
206 |
[GO] |
2020―Sep―12 |
SARS-CoV-2 and its Predicted Potential Natural Inhibitors: A Review and Perspective |
Priyanka Samji, Manoj Kumar Rajendran, Vidya P Warrier |
207 |
[GO] |
2020―Sep―09 |
Dealing with COVID-19: lessons learned from the Italian experience |
Silvana Mirella Aliberti, Francesco De Caro, Giovanni Boccia, Rosario Caruso, Mario Capunzo |
208 |
[GO] |
2020―Sep―05 |
A Brief outlook on possible available solutions, therapies and suggestions for COVID-19 |
Rashmi Saxena Pal, Yogendra Pal, Pranay Wal, Ankita Wal, Nikita Saraswat |
209 |
[GO] |
2020―Sep―05 |
COVID-19: A comparative study of SARS, MERS and COVID-19 |
Chandra Mohan, Vinod Kumar |
210 |
[GO] |
2020―Sep―05 |
Impacts and consequences of COVID-19 epidemic on global economy |
Pallavi Nayak, Vijay Mishra, Manvendra Singh, Murtaza M. Tambuwala |
211 |
[GO] |
2020―Sep―05 |
COVID-19 Pandemic: Age and Temperature Related Effects |
Gursharan Kaur, Amandeep Singh, Raj Kumar Narang, Gurmeet Singh |
212 |
[GO] |
2020―Sep―05 |
Non-Pharmaceutical Interventions are measures to control coronavirus disease-2019 (COVID-19) transmission in India |
Ponnuswamy Vijayaraghavan, Srikrishnan Rajendran Sriramkumar |
213 |
[GO] |
2020―Sep―05 |
The outbreak of Novel Coronavirus a New Type of Threat in 2020: Genesis, Detection, Treatment, and Management |
Dinesh Mohan S, Santhosha D, Gupta VRM, Mrunalini S |
214 |
[GO] |
2020―Sep―02 |
Novel Coronavirus in India Outbreaks around World: A Statistical Analysis of Odisha, India & World |
Debabrata Singh, Suman Sekhar Sarangi, Milu Acharya, Surjeet Sahoo, Shakti Ketan Prusty, Sudhanshu Rout |
215 |
[GO] |
2020―Aug―27 |
Virtual screening of potential therapeutic inhibitors against spike, helicase and polymerase of SARS-CoV-2 (COVID-19) |
Ayesha Tazeen, Farah Deeba, Aftab Alam, Rafat Ali, Romana Ishrat, Anwar Ahmed, et al. (+2) Sher Ali, Shama Parveen |
216 |
[GO] |
2020―Aug―27 |
A Mini Review: Origin, Treatments, Preventions, Real Facts and Viability of the Recent Pandemic of Novel Coronavirus-2019 |
Prashant Kantrao Vibhute, Satish Babulal Jadhav, Satish Ashruba Dake, Bhaskar Sadashiv Dawane |
217 |
[GO] |
2020―Aug―26 |
The COVID-19 and Munchausen Syndrome |
Yadollah Abolfathi Momtaz |
218 |
[GO] |
2020―Aug―22 |
Measuring Asymptomatic Growth of COVID-19; A Powerful Mechanism for Controlling the Disease Spread |
Keith Lau |
219 |
[GO] |
2020―Aug―19 |
Dengue, Influenza and COVID-19 in Brazil: The "Perfect Storm" |
Rosineide Marques Ribas, Paola Amaral de Campos, Cristiane Silveira de Brito, Paulo Pinto Gontijo Filho |
220 |
[GO] |
2020―Aug―19 |
An Overview on Covid-19: Clinical Features, Treatment and Prevention |
Shahid Ud Din Wani, Surya Prakash Gautam, Zulfkar Latief Qadrie |
221 |
[GO] |
2020―Aug―16 |
COVID-19: A Review on Epidemiology, Clinical Features and Possible Potential Drugs Based on Available Case Studies |
Kirtikumar C. Badgujar, Dipak V. Patil, Dipak V. Dhangar, Vikrant P. Patil, Ashish B. Badgujar |
222 |
[GO] |
2020―Aug―16 |
COVID-19: The Unprecedented Malady-A Holistic Review |
Viney Chawla, Pooja A Chawla |
223 |
[GO] |
2020―Aug―03 |
Homology Modeling of Coronavirus Structural Proteins and Molecular Docking of Potential Drug Candidates for the Treatment of COVID-19 |
Ahmed Adebayo Ishola, Nnaemeka Tobechukwu Asogwa |
224 |
[GO] |
2020―Aug―02 |
Coordinated Roadmap to Grip Pandemic Covid-19 |
Rohini S. Kharwade, Sachin M. More |
225 |
[GO] |
2020―Jul―30 |
Favipiravir in the Spotlight: In search of treatment against COVID-19 |
Marcus Vinícius Nora de Souza, Victor Facchinetti |
226 |
[GO] |
2020―Jul―30 |
Off label medication to combat COVID-19: Review Results to Date. |
Amita Verma, Anuj Kumar Singh, Aman K. Das, Netra P. Neupane |
227 |
[GO] |
2020―Jul―30 |
Self-Protection of Medical Workers in Traditional Hospitals and Clinics against SARS-CoV-2 Infection |
Suneel Prajapati, Pankaj Gupta, Digvijay Verma, Shilpi Singh, Ashish Tripathi, Mahima Sharma, et al. (+2) Arun Kumar, G.V Narasimha Kumar |
228 |
[GO] |
2020―Jul―22 |
A Note on Estimating the Case Fatality Ratio for Novel Corona Virus Disease (Covid-19) |
Prafulla Kumar Swain |
229 |
[GO] |
2020―Jul―22 |
SARS-CoV-2 Therapy: Old drugs as new interventions |
Puneet K. Samaiya, Mahendra Kumar |
230 |
[GO] |
2020―Jul―14 |
Study of the Relationships Between COVID-19, Associated Diseases, and Vitamins |
Alice Barros Câmara, Igor Augusto Brandão |
231 |
[GO] |
2020―Jul―14 |
Amantadine Can be Used as a Drug for SARS-Cov-2 Treatment? |
Zeynep Gunes Ozunal, Sevki Sahin |
232 |
[GO] |
2020―Jul―14 |
Symptoms, transmission, prevention and treatment of pandemic corona virus: A review |
Tinsae Kebede, Dharmendra Kumar, Pramod Kumar Sharma |
233 |
[GO] |
2020―Jul―10 |
Pathogenesis, Clinical Manifestation, Diagnosis, Pathological Findings, Treatment Options, Preventive Measures and Risk Factors Of Covid-19 |
Mohammad Asif, Anshuman Patel, May Bin-Jumah, Sadaf Jamal Gilani, Iqra Rahat, Mohamad Taleuzzaman, et al. (+3) Neha Gandhi, Syed Sarim Imam, Chandra Kala |
234 |
[GO] |
2020―Jul―10 |
Covid-19: Doomsday, Shoved Away? |
Zahid Dar, Lucky Chauhan, Monika Chauhan, Navpreet Kaur, Tanzeer Kaur, Neelima Dhingra |
235 |
[GO] |
2020―Jul―02 |
Revealing potential binding affinity of FDA approved therapeutics targeting Main protease (3CLpro) in impairing novel coronavirus (SARS-CoV-2) replication that causes COVID-19 |
D. Sivaraman, P.S. Pradeep, S. Sundar Manoharan, C. Ramachandra Bhat, K.V. Leela, V. Venugopal |
236 |
[GO] |
2020―Jul―02 |
The comprehensive appraisal of COVID-19, it’s clinical panorama from virology till management and beyond. |
Iftikhar Haider Naqvi, Saiyeda Nayema Zehra Rizvi |
237 |
[GO] |
2020―Jul―02 |
Potential Drug Options for Treatment Process of COVID-19: A Review |
Tinsae Kebede, Dharmendra Kumar, Pramod Kumar Sharma |
238 |
[GO] |
2020―Jul―02 |
Impact and Inescapable Effects of Coronavirus: History to Modern Pandemic Episode |
Suman K Ray, Yamini Meshram, Sukhes Mukherjee |
239 |
[GO] |
2020―Jun―29 |
A note on the potential BCG vaccination - COVID-19 molecular link |
Alex Y. Strongin, Alex Sloutsky, Piotr Cieplak |
240 |
[GO] |
2020―Jun―26 |
Activity of some novel Chalcone substituted 9-anilinoacridines against Coronavirus (COVID19): A computational approach |
Rajagopal Kalirajan |
241 |
[GO] |
2020―Jun―26 |
Potential immunotherapy against SARS-CoV-2: Strategy and status |
Abid H. Banday, Shameem A. Shah, Sheikh J. Ajaz |
242 |
[GO] |
2020―Jun―24 |
Critical insight into the attributes of emerging novel Coronavirus (COVID-19) in India and across the world |
Gaurav M Doshi, Hemen S Ved, Ami P Thakkar |
243 |
[GO] |
2020―Jun―24 |
COVID-19: Opinion in Prevention and dietary based management hypothesis |
Ashraf Talaat Youssef |
244 |
[GO] |
2020―Jun―22 |
The COVID-19 and Ageism in Social Media |
Yadollah Abolfathi Momtaz |
245 |
[GO] |
2020―Jun―22 |
Unfortunate Welcome of Evil nCovid-19 in 2020: From Despair to Hope |
Ravi Varala, Haribabu Bollikolla |
246 |
[GO] |
2020―Jun―17 |
Coronavirus (COVID-19) Effects on Psychological Health of Indian Poultry Farmers |
Gaurav Dhiman |
247 |
[GO] |
2020―Jun―17 |
Update on the SARS-CoV-2 (COVID-19) Outbreak: A Global Pandemic Challenge |
Abhishek Kumar Soni |
248 |
[GO] |
2020―Jun―17 |
COVID-19: could irisin become the handyman myokine of the 21th century? |
Alessia Catalano |
249 |
[GO] |
2020―Jun―17 |
COVID-19: Morphology, Characteristics, Symptoms, Prevention, Clinical Diagnosis and Current Scenario |
Tansukh Barupal, Praveen Kumar Tak, Mukesh Meena |
250 |
[GO] |
2020―Jun―17 |
Repurposing of RdRp Inhibitors against SARS-CoV-2 through Molecular Docking Tools. |
Rohit Bhatia, Raj Kumar Narang, Ravindra Kumar Rawal |
251 |
[GO] |
2020―Jun―17 |
Understanding the Molecular Mechanism(s) of SARS-CoV2 Infection and Propagation in Human to Discover Potential Preventive and Therapeutic Approach |
Sibi Raj, Vaishali Chandel, Brijesh Rathi, Dhruv Kumar |
252 |
[GO] |
2020―Jun―15 |
A Preliminary Review on Novel Coronavirus Disease: COVID-19 |
Miranji Katta, Satish Rapaka, Ramkumar Adireddi, Jagadeeshwara Rao Emandi |
253 |
[GO] |
2020―Jun―07 |
The Relationship between Opium Use and Coronavirus Infection, A Brief Research Report from Iran |
Hadi Khoshab, Mohammadreza Rajabalipour |